Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | STAT3 | P40763 | 1/20 | 0.45 |
| ▸ | STAT1 | P42224 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL514858 | 1.00 | CA9 (0.56) | CA9ALDH1A1LMNACES2CES1 | |
| SCHEMBL12741076 | 1.00 | CA9 (0.56) | CA9ALDH1A1LMNACES2CES1 | |
| SCHEMBL28264695 | 0.97 | CA9 (0.54) | CA9ALDH1A1LMNACES2CES1 | |
| SCHEMBL8306282 | 0.93 | CA9 (0.51) | CA9ALDH1A1LMNACES2CES1 | |
| SCHEMBL12360950 | 0.89 | CA9 (0.52) | CA9ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL14298196 | 0.89 | CA9 (0.52) | CA9ALDH1A1LMNASMN1; SMN2MAPT | |
| Toluene SCHEMBL28232902 | 0.83 | LMNA (0.50) | CA9ALDH1A1LMNACES2CES1 | |
| SCHEMBL12082305 | 0.82 | CA9 (0.44) | CA9ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL10886275 | 0.82 | CA9 (0.44) | CA9ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL13645704 | 0.81 | CA9 (0.47) | CA9ALDH1A1LMNASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119059919-A | Process for preparing 1- (4-methylphenyl) ethylamine | 山东智荟检测科技有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-117720433-A | Preparation method and application of oxime carbonate compound | 河南农业大学 | 2024-03-19 | — | — | CN | claimed |
| CN-112574135-B | 4-aryl-5-thioether-2-difluoromethyl oxazole, and derivatives and synthesis method thereof | 湖南工程学院 | 2022-09-23 | — | — | CN | claimed |
| CN-112574135-A | 4-aryl-5-thioether-2-difluoromethyl oxazole, and derivatives and synthesis method thereof | 湖南工程学院 | 2021-03-30 | — | — | CN | claimed |
| CN-108355709-B | Application of bismuth trifluoromethanesulfonate as Beckmann rearrangement reaction catalyst | 嘉兴学院 | 2020-12-08 | — | — | CN | claimed |
| CN-109705146-A | 2- amino benzo [4,5] thieno [3,2-d] thiazole, derivative and its synthetic method | 湘潭大学 | 2019-05-03 | — | — | CN | claimed |
| CN-106518707-B | Method for preparing amide | 南京工业大学 | 2018-02-06 | — | — | CN | claimed |
| CN-107011201-A | Preparation method of amide | 南京工业大学 | 2017-08-04 | — | — | CN | claimed |
| CN-106518707-A | Method for preparing amide | 南京工业大学 | 2017-03-22 | — | — | CN | claimed |
| CN-119059919-A | Process for preparing 1- (4-methylphenyl) ethylamine | 山东智荟检测科技有限公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-118440019-A | Triazinyl diketone oxime ester compound and preparation method and application thereof | 湖南省农业生物技术研究所 | 2024-08-06 | — | — | CN | disclosed |
| CN-117720433-A | Preparation method and application of oxime carbonate compound | 河南农业大学 | 2024-03-19 | — | — | CN | disclosed |
| US-20230172206-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS II | BASF SE (DE) | 2023-06-08 | — | — | US | disclosed |
| CN-110642748-B | O- (2-trifluoromethyl-2-hydroxyethyl) oxime ether derivative and synthetic method and application thereof | 华南理工大学 | 2023-03-31 | — | — | CN | disclosed |
| US-5213946-A | POSITIVE TYPE, PHOTOSENSITIVE RESINOUS COMPOSITION | NIPPON PAINT CO., LTD. (JP) | 1993-05-25 | — | — | US | disclosed |
| EP-0519128-A1 | A positive type, photosensitive resinous composition | Nippon Paint Co., Ltd. (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-4869995-A | Positive type photosensitive resinous composition | NIPPON PAINT CO., LTD. (JP) | 1989-09-26 | — | — | US | disclosed |
| EP-0293058-A2 | A positive photosensitive resinous composition | Nippon Paint Co., Ltd. (JP) | 1988-11-30 | — | — | EP | disclosed |
| US-4086243-A | Intermediates in the preparation of isoxazolyl benzamides | SANDOZ, INC. (US) | 1978-04-25 | — | — | US | disclosed |
| US-3987179-A | ISOXAZOLYL BENZAMIDES AS PHARMACOLOGICAL AGENTS | SANDOZ, INC. (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172206-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS II | COX5B, SQOR, UQCRB | CA9 598/4885ALDH1A1 4256/4885LMNA 3500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.